Kiadis Pharma BV of the Netherlands has entered into a licensing deal with Hospira Inc of the US to develop and commercialise its haematology product for blood cancer patients who need a bone marrow transplant but can’t find a matched donor. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
